Hosseini et al. discovered that resveratrol can mitigate NAFLD by inducing epigenetic modifications of the Nrf2-Keap1 signaling pathway, significantly reducing high glucose-induced triglyceride accumulation in HepG2 cells (61). This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.